Drugs / Kolofort
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03119766 | Jun 2017 → Jan 2020 | dyspepsia | Materia Medica Holding | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kolofort | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03119766 ↗ |
| Route | Oral | “Oral administration” NCT03119766 ↗ |